Treatment of chronic inflammatory diseases with implantable medical devices

Annals of the Rheumatic Diseases

Volumn 70, Issue SUPPL. 1, 2011, Pages

  Zitnik, Ralph J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD11B ANTIGEN; CXCL2 CHEMOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; LIPOPOLYSACCHARIDE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; CD4+ CD25+ T LYMPHOCYTE; CHOLINERGIC SYSTEM; CHRONIC INFLAMMATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DEPRESSION; DEVICE THERAPY; DISEASE SEVERITY; ELECTRODE; ELECTROSTIMULATION; EPILEPSY; HEART RATE VARIABILITY; HUMAN; LYMPHOCYTE PROLIFERATION; NONHUMAN; PACEMAKER; PRIORITY JOURNAL; PULSE GENERATOR; RR INTERVAL; VAGOTOMY; VAGUS NERVE; VAGUS NERVE STIMULATION; VAGUS TONE; ANIMAL; CHOLINERGIC NERVE; CHRONIC DISEASE; DISEASE MODEL; ELECTROSTIMULATION THERAPY; INFLAMMATION; METHODOLOGY; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; CHOLINERGIC STIMULATION; IMPLANTABLE NEUROSTIMULATOR; RHEUMATOID ARTHRITIS;

ANIMALS; CHOLINERGIC FIBERS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; HUMANS; INFLAMMATION; NEURAL PATHWAYS; VAGUS NERVE;

EID: 79953016230     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.138677     Document Type: Conference Paper

References (26)

1. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
2. van Maanen MA, Vervoordeldonk MJ, Tak PP. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol 2009;5:229-32.
3. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009;9:418-28.
4. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-62. (Pubitemid 30367422)
5. Huston JM, Ochani M, Rosas-Ballina M, et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006;203:1623-8.
6. Rosas-Ballina M, Ochani M, Parrish WR, et al. Splenic nerve is required for cholinergic antiinflammtory pathway control of TNF in endotoxemia. Proc Natl Acad Sci. 2008;105:11008-13.
7. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421:384-8. (Pubitemid 36157937)
8. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004;10:1216-21. (Pubitemid 39540438)
9. de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005;6:844-51.
10. Huston JM, Rosas-Ballina M, Xue X, et al. Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 2009;183:552-9.
11. O'Mahony C, van der Kleij H, Bienenstock J, et al. Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol 2009;297:R1118-26.
12. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, et al. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006;131:1122-30. (Pubitemid 44498700)
13. Ghia JE, Blennerhassett P, Collins SM. Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G560-7.
14. Karimi K, Bienenstock J, Wang L, et al. The vagus nerve modulates CD4+ T cell activity. Brain Behav Immun 2010;24:316-23.
15. Huston JM, Gallowitsch-Puerta M, Ochani M, et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007;35:2762-8. (Pubitemid 350175773)
16. Levine Y, Faltys M, Black K, et al. Neurostimulation of the cholinergic anti-inflammatory pathway (NCAP) ameliorates CIA in rats. Ann Rheum Dis. 2010;69 (Suppl 3):191.
17. Zhang Y, Popovic ZB, Bibevski S, et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2009;2:692-9.
18. Gupta RC, Imai M, Jiang AJ, et al. Chronic therapy with selective vagus nerve stimulation normalizes plasma concentration of tumor necrosis factor alpha, interleukin-6, and B-type natriuretic peptide in dogs with heart failure. J Am Coll Cardiol. 2006;47:77A.
19. Beekwilder JP, Beems T. Overview of the clinical applications of vagus nerve stimulation. J Clin Neurophysiol 2010;27:130-8.
20. Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 2001;18:415-18. (Pubitemid 33111566)
21. Heck C, Helmers SL, DeGiorgio CM. Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 2002;59(6 Suppl 4):S31-7.
22. Huikuri HV, Jokinen V, Syvänne M, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1979-85. (Pubitemid 29379932)
23. Sajadieh A, Nielsen OW, Rasmussen V, et al. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363-70. (Pubitemid 38391517)
24. Louthrenoo W, Ruttanaumpawan P, Aramrattana A, et al. Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus. QJM 1999;92:97-102. (Pubitemid 29097634)
25. Evrengül H, Dursunoglu D, Cobankara V, et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 2004;24:198-202. (Pubitemid 39062488)
26. Stojanovich L, Milovanovich B, de Luka SR, et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases. Lupus 2007;16:181-5. (Pubitemid 46506595)